<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7FB818E8-1AEA-4A45-B3E2-B85E723A2DB1"><gtr:id>7FB818E8-1AEA-4A45-B3E2-B85E723A2DB1</gtr:id><gtr:name>Science for Life Laboratory</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5C5043CE-84CE-47DF-A2F9-2C42D2F56651"><gtr:id>5C5043CE-84CE-47DF-A2F9-2C42D2F56651</gtr:id><gtr:name>University of Ibadan</gtr:name><gtr:address><gtr:line1>Ibadan</gtr:line1><gtr:line4>Oyo State</gtr:line4><gtr:line5>Nigeria</gtr:line5><gtr:postCode>900001</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Nigeria</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7FB818E8-1AEA-4A45-B3E2-B85E723A2DB1"><gtr:id>7FB818E8-1AEA-4A45-B3E2-B85E723A2DB1</gtr:id><gtr:name>Science for Life Laboratory</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5C5043CE-84CE-47DF-A2F9-2C42D2F56651"><gtr:id>5C5043CE-84CE-47DF-A2F9-2C42D2F56651</gtr:id><gtr:name>University of Ibadan</gtr:name><gtr:address><gtr:line1>Ibadan</gtr:line1><gtr:line4>Oyo State</gtr:line4><gtr:line5>Nigeria</gtr:line5><gtr:postCode>900001</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Nigeria</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/251EF468-7623-4BF2-A1D8-1119CD402669"><gtr:id>251EF468-7623-4BF2-A1D8-1119CD402669</gtr:id><gtr:firstName>Delmiro</gtr:firstName><gtr:surname>Fernandez-Reyes</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117585869"><gtr:id>98054DF4-1541-4D7D-8946-FC8830A7F3BF</gtr:id><gtr:title>Proteome Wide Study of Host-Parasite Interactions in Malaria Infections</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117585869</gtr:grantReference><gtr:abstractText>The programme aims to capture the relationships among the multiple sets of components that define the host-parasite interaction during a malaria infection. |The work relies on the use of both experimental techniques that take a snapshot of the state of the infection and computational methods. Identification of these processes is essential for understanding the different severe malaria clinical presentations and provides relevant information for the development of new diagnostic tests and therapeutic strategies.</gtr:abstractText><gtr:technicalSummary>Biomedical research in the post -omic age is currently influenced by systems biology approaches. The feasibility of capturing context-dependant molecular data of the components of an organism provides us with a view into the complex interactions that occur between a pathogen and its host.||Current malaria -omic information is primarily focused on the parasites molecular components. However, this information does not capture the way in which molecular components of both host and parasite interact to establish a specific disease state.||This programme aims to identify sets of molecules involved in specific pathogenic processes such as cerebral malaria and severe malarial anaemia. This programme also intends to extend our approach to examine a range of clinical presentations of human and mouse malaria infections and scenarios such as TB-malaria-HIV co-infections.||The programme has at its centre the study of the molecular basis of human malaria infections using mass spectrometry methods for high-throughput study of complex protein mixtures and computational analysis of the profiles obtained. State-of-the-art mass spectrometry (e.g. Surface-Enhanced Laser Desorption-Ionization Time-of-Flight SELDI-ToF) is used to capture a snapshot of the molecular components involved in a particular state of malarial infection. Computational and biochemical analysis of these complex profiles will allow us to identify molecular components and relationships among them that may provide an understanding of the pathological processes of malaria infection. Our results in the tuberculosis field showed that serum proteome profiling can provide disease-specific molecular proteome fingerprints reflecting host-pathogen interactions (Fernandez-Reyes, Agranoff et al. 2006). Moreover, our findings are the basis of diagnostic methods currently going into the patenting and validation process.||This systems biology programme relies on an tight integration of clinical, in vitro, in vivo and in silico work:|- Proteomic fingerprinting of serum, plasma, cerebro spinal fluid, bone marrow and urine from human and mouse malaria infections.|- Development and deployment of integrative statistical computational methods for the analysis of proteome fingerprints and post omic data.|- Identification of sets of molecules defining specific pathogenic processes such as severe malaria anaemia.|- Functional analysis of identified molecular components and evaluation of their possible use in diagnosis and/or therapeutics.|- Analysis of protein-protein interactions between identified host-pathogen molecules.</gtr:technicalSummary><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-09-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2918630</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>We have been using street art at permitted locations across London touching in some awareness of TB and Malaria</gtr:description><gtr:id>C2EB6FD2-EF5B-4F2F-8F60-838C7B86CE1A</gtr:id><gtr:impact>Other artist became engaged and are now part of a network of street artist that will seek funding to explore further the use of this
art form for increasing global health awareness</gtr:impact><gtr:outcomeId>546649581f7638.34756870</gtr:outcomeId><gtr:title>Collaboration with Street Art artist to use it as a media to engage the public in global health problems such as Malaria and TB</gtr:title><gtr:type>Artwork</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Computer Science</gtr:department><gtr:description>Computational Analysis of Complex Biological Patterns</gtr:description><gtr:id>AC1F5466-71F1-4DDB-995C-728046CB51CB</gtr:id><gtr:impact>PubMed ID 16980117 PubMed ID 18509521</gtr:impact><gtr:outcomeId>678015B277D-1</gtr:outcomeId><gtr:partnerContribution>Access to novel computational statistics methods for the analysis of complex biological datasets such as proteomics</gtr:partnerContribution><gtr:piContribution>We design algorithms and analysis frameworks in close relation to computational statistic theoreticians. My laboratory provides both the applied domain specific computational expertise and the relevant datasets that represent the biomedical hypothesis of interest.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Biomarker Discovery for Diagnosis of Active Tuberculosis</gtr:description><gtr:id>80632084-E564-427A-B2C9-039685ED20E3</gtr:id><gtr:impact>Lancet Paper (2006) PubMed ID 16980117</gtr:impact><gtr:outcomeId>C83C3B236CD-2</gtr:outcomeId><gtr:partnerContribution>access to clinical samples and proteomics platformsaccess to clinical samples</gtr:partnerContribution><gtr:piContribution>We contributed on clinical study design and sample collection protocols. Proteomic experiments have been carried out in my laboratory BioSafety Containment 3 room using our SELDI-ToF mass spectrometer. We also designed and implemented the complex statistical analysis framework to discover biomarkers of TB infection from proteomic data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Department of Microbiology, Tumour and Cell Biology</gtr:department><gtr:description>Immuno Proteomics of Severe Malaria</gtr:description><gtr:id>D62592CF-4128-42EA-82F3-D84A21DC0288</gtr:id><gtr:impact>We have now discovered a panel of biomarkers of malaria severe disease. We are now writing a manuscript with the main findings and we plan to move forward a panel of severity biomarkers in the near future</gtr:impact><gtr:outcomeId>jYJQNuJCxXX-1</gtr:outcomeId><gtr:partnerContribution>They have provided a library of over 10,000 antibodies to human plasma proteins for a large scale screen. They have provided also a post-doctoral scientist to carry out the work.</gtr:partnerContribution><gtr:piContribution>We provided samples from our case-control study of severe malaria</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ibadan</gtr:collaboratingOrganisation><gtr:country>Nigeria, Federal Republic of</gtr:country><gtr:department>Department of Paediatrics</gtr:department><gtr:description>Proteome-Wide Discovery of Host-Parasite Interactions During Severe Malaria</gtr:description><gtr:id>C673BC1B-28B5-41A5-803A-E5164910245A</gtr:id><gtr:impact>This partnership has founded the Childhood Malaria Research Unit based at the University College Hospital Ibadan Nigeria. We have concluded the case-control recruitment for the discovery part of the project with 2000 individuals recruited over a period of three years.</gtr:impact><gtr:outcomeId>C317176151A-1</gtr:outcomeId><gtr:partnerContribution>Assignment of 2 Paediatrics Registrars for Project Sample Collection Assignment of a malaria laboratory technician. Assignment of one project data manager. Clinical and laboratory facilities at Hospital Site Access to severe malaria clinical cases and outpatient clinics Clinical Sample Collection</gtr:partnerContribution><gtr:piContribution>I have design the case-control study to discovery potential proteomic biomarkers of severity in malaria infections. The work is focused on Severe Malaria Anaemia and Cerebral Malaria. My research team designs and implements all the proteomics data generation from clinical specimens in our Bio Safety Level 3 room. My computational research team designs and implements complex computational statistics frameworks to analyse proteome patterns on these severe forms of malaria.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cellular and Molecular Medicine</gtr:department><gtr:description>Biomarker Discovery for Diagnosis of Active Tuberculosis</gtr:description><gtr:id>7CB08E2A-F1B5-46F9-A548-42A10DDF907C</gtr:id><gtr:impact>Lancet Paper (2006) PubMed ID 16980117</gtr:impact><gtr:outcomeId>C83C3B236CD-1</gtr:outcomeId><gtr:partnerContribution>access to clinical samples and proteomics platformsaccess to clinical samples</gtr:partnerContribution><gtr:piContribution>We contributed on clinical study design and sample collection protocols. Proteomic experiments have been carried out in my laboratory BioSafety Containment 3 room using our SELDI-ToF mass spectrometer. We also designed and implemented the complex statistical analysis framework to discover biomarkers of TB infection from proteomic data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Latent Tuberculosis Biomarker Discovery</gtr:description><gtr:id>4AAD0B6C-D93C-4C83-88A7-B83B73925287</gtr:id><gtr:impact>We have concluded sample collection of Latent TB cases in Peru over a period of two years. We now generated proteomic signatures that discriminate the Latent TB cases and current efforts are focus on determining a subset of these proteins to be pipelined into the biomarker validation phase.</gtr:impact><gtr:outcomeId>D0AC4C0B59A-1</gtr:outcomeId><gtr:partnerContribution>access to clinical samples</gtr:partnerContribution><gtr:piContribution>We contributed on clinical study design and sample collection protocols. Proteomic experiments have been carried out in my laboratory BioSafety Containment 3 room using our SELDI-ToF mass spectrometer. We also designed and implemented the complex statistical analysis framework to discover biomarkers of TB infection from proteomic data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Science for Life Laboratory</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Immuno Proteomics of Severe Malaria</gtr:description><gtr:id>5E38E4C5-AC9B-48AA-8D2A-903F0D4DE493</gtr:id><gtr:impact>We have now discovered a panel of biomarkers of malaria severe disease. We are now writing a manuscript with the main findings and we plan to move forward a panel of severity biomarkers in the near future</gtr:impact><gtr:outcomeId>jYJQNuJCxXX-2</gtr:outcomeId><gtr:partnerContribution>They have provided a library of over 10,000 antibodies to human plasma proteins for a large scale screen. They have provided also a post-doctoral scientist to carry out the work.</gtr:partnerContribution><gtr:piContribution>We provided samples from our case-control study of severe malaria</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Vaccination Clinics</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2A6BF817-C22C-4898-8AED-44595F5AA03B</gtr:id><gtr:impact>Parents of children attending well children vaccination clinics attend for routine vaccinations

Parents are interested to get the children blood group and sickle trait results that are carried out when the children is recruited into the malaria case-control study</gtr:impact><gtr:outcomeId>MLhFhRg7353</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visits - Ibadan Nigeria</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6325185E-BEEF-4EF1-9220-19AA95167728</gtr:id><gtr:impact>We engage with schools in Ibadan centre to do malaria parasite screening in healthy children. We do disease awareness, explain results to parents, teachers and children. We explain how the research will have an impact in predicting what children may develop severe presentations of the malaria infection

Several schools contact us to provide regular screening and awareness sessions as well as discussion to parents and teachers in the Ibadan area.</gtr:impact><gtr:outcomeId>CAB9ABE2F17</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EVIMALAR European Network of Excellence in Malaria Research</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>EVIMalaR</gtr:fundingOrg><gtr:id>D6F0AE5D-3F2A-4F68-ABB0-199B7AE7DDB9</gtr:id><gtr:outcomeId>57a370e70d3b40.65259025</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>G6PD screening in holoendemic malaria area attending tertiary care</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>D9FA87FF-E3D3-4196-94C2-EE0B7F06C1B7</gtr:id><gtr:impact>The routine screen has had an impact on training and the paediatric care of the tertiary hospital</gtr:impact><gtr:outcomeId>msKHyGYbBK5</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>case-control study severe malaria</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>F1854947-677E-458C-92AD-7F58227E6B4A</gtr:id><gtr:impact>The case-control study of severe malaria based in a tertiary hospital has had a tremendous impact on training at all levels from nurses to medical trainees. Sample collection protocols have introduced clear standards that have had an impact in patient care</gtr:impact><gtr:outcomeId>KSDpwNXM8BR</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Malaria Screening at University College Hospital Ibadan, Nigeria</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>5B0AB7B6-2FDB-457E-8DEE-EB3462C034BB</gtr:id><gtr:impact>We have design and deploy malaria screening quality control protocols that are in use in the UCH Ibadan and are also the backbone of our current malaria proteomics research project. This has an impact on malaria treatment and therefore in the disease outcome and rational administration of antimalarials. We have also introduced new methods for data acquisition in the complex hospital setting this has had a tremendous impact in care to the patient, clinicians and technicians training as well as malaria research in the Paediatric Department</gtr:impact><gtr:outcomeId>23C725CA7FA</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Iron supplementation in childhood severe malaria</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>23503B89-243A-46BC-941A-88AE1EDF232F</gtr:id><gtr:impact>The impact on tertiary care of severe malaria cases has been influenced by our research to an extend that instantiated a national review of the guidelines for iron supplementation in children with severe presentations of malaria. We have shown molecular evidence that supplementation in these cases is not required</gtr:impact><gtr:outcomeId>57a36c539ccfe0.50130739</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>We have discovered the serum proteome pattern that discriminate Active Tuberculosis. We have postulated a set of biomarkers from this profile to be taken to a biomarker validation pipeline.</gtr:description><gtr:id>37A4ED83-CCC6-4AB1-A8A4-19382BAAF1CD</gtr:id><gtr:impact>Diagnostic of Active Tuberculosis is a challenging problem on Global Health, we have provided an alternative and reliable method to detect the disease process that does not requires to wait for 3 weeks as the sputum culture method.</gtr:impact><gtr:outcomeId>4F0B06A7FA2</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Active TB diagnostic test</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2006</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Database of large case-control study focused on severity biomarker discovery
SQL database with clinical, laboratory and experimental data</gtr:description><gtr:id>81ABC6A5-17A4-44A2-9D05-CB07E1BCE764</gtr:id><gtr:impact>This large study is producing new findings of molecules that correlate with childhood severe malaria</gtr:impact><gtr:outcomeId>5466486a206289.68677553</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Case-Control Severe Malaria Study Clinical Database</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We developed a new algorithm to estimate relevant biomarkers on data such proteomic or microarray profiles. We provide the software for academic users for several biomarker discovery projects</gtr:description><gtr:id>FF40879E-A245-4C01-B284-F503DDCC8B2F</gtr:id><gtr:impact>Several groups are using our software to select biomarkers on their data.</gtr:impact><gtr:outcomeId>3E62EDD2801</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Estimation of biomarkers using iterated weighted kernel functions</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have discovered a novel plasma biomarker of active tuberculosis.</gtr:description><gtr:id>A38B94F4-781D-438E-B701-93DF0A908F5F</gtr:id><gtr:impact>We are in the process to publish our results. We are planing to move this biomarker forward to the clinic</gtr:impact><gtr:outcomeId>ANZ3hh1weDs</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Active TB plasma biomarker</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>discovery of haptoglobin polymorphism that is associated with low levels of plasma haptoglobin</gtr:description><gtr:id>3BAA02D9-83B8-4F8C-8856-502924023B0B</gtr:id><gtr:impact>our finding has now prompted a prospective large clinical validation study</gtr:impact><gtr:outcomeId>57a36d6c67c8f0.53320124</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>discovery of haptoglobin polymorphisms associated with severe malarial anaemia</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>we have validated a panel of protein plasma biomarkers for diagnosis, progression and outcome of childhood severe malaria</gtr:description><gtr:id>B144DBF2-F64A-4F61-81DD-BEC66341F310</gtr:id><gtr:impact>our validate panel is now deployed for clinical validation in tertiary care in sub-Saharan Africa urban areas of Nigeria</gtr:impact><gtr:outcomeId>57a36cf5075b87.28580816</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>plasma biomarkers of severe childhood malaria</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>As part of the case-control study of childhood severe malaria we have collected serum, plasma, urine and csf on 3000 recruited patients. This is one of the largest and comprehensive malaria sample set currently available. Furthermore, it is one of the unique well clinically characterised set.</gtr:description><gtr:id>169357D4-6E8A-41F7-BC80-36035100EBCF</gtr:id><gtr:impact>We have now have discover markers associated with the pathogenesis of childhood severe malaria</gtr:impact><gtr:outcomeId>a58YMXp1Abs</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>large case-control study of childhood severe malaria</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have obtained serum proteomic signatures that discriminate Active Tuberculosis with diagnostic accuracy over 90%. We have discover set of biomarkers that are into the validation phase</gtr:description><gtr:id>8E46A2BB-4910-4678-BDAC-BB0BF3131E9F</gtr:id><gtr:impact>Patent applied for May 2005. revenue share agreement with St George's Hospital, University of London</gtr:impact><gtr:outcomeId>6B7E6C54D2C</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Active TB diagnostic test</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>SCCA is a new algorithm developed with colleagues at Department of Computer Science UCL London (Prof. John Shawe-Taylor) and in Finland (Dr Juho Rouso)</gtr:description><gtr:id>0CA939C2-592A-46C6-BF97-FB2F39A8EB63</gtr:id><gtr:impact>We distribute the software via request to the senior authors of the software that is used for biomarker discovery.</gtr:impact><gtr:outcomeId>546647e5692d43.35114418</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>SCCA software</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>SCCA is a novel biomarker discovery algorithm that allow the correlation of multivariate data against multivariate clinical complex phenotypes</gtr:description><gtr:id>0F8D8481-D49E-4FE6-A8D8-2B756A44742D</gtr:id><gtr:impact>We have now been involved in analysing datasets from several communicable diseases such as RSV, TB and Malaria</gtr:impact><gtr:outcomeId>546649df2e4965.94572983</gtr:outcomeId><gtr:title>Sparse Canonical Correlation Analysis Software</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>A machine learning to discovery relevant variable of multidimensional biological datasets</gtr:description><gtr:id>CBE09FA6-8B1A-4E60-8E4D-20388500C75B</gtr:id><gtr:impact>it is a stablished method to discover relevant combination of variable in multidimensional biological datasets</gtr:impact><gtr:outcomeId>57a36e3fcc8711.47157914</gtr:outcomeId><gtr:title>Relevant variable selection for large -omics datasets WKIDEA Machine Learning Software</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5F6A670F-DA51-4269-9816-B3371B8B2E90</gtr:id><gtr:title>Circulatory hepcidin is associated with the anti-inflammatory response but not with iron or anemic status in childhood malaria.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f2bc8ccf2f361fa8c5a2eebff8fa9de"><gtr:id>1f2bc8ccf2f361fa8c5a2eebff8fa9de</gtr:id><gtr:otherNames>Burt? F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_16449_29_23380741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84A5FA77-C24E-4101-84A2-E783D3BBC501</gtr:id><gtr:title>Global transcriptional analysis of primitive thymocytes reveals accelerated dynamics of T cell specification in fetal stages.</gtr:title><gtr:parentPublicationTitle>Immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b07bc34af52e437bb4d8bb58334db9e5"><gtr:id>b07bc34af52e437bb4d8bb58334db9e5</gtr:id><gtr:otherNames>Belyaev NN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0093-7711</gtr:issn><gtr:outcomeId>pm_16449_29_22581009</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63EF995A-2BDD-49F6-8398-98D66067D2FD</gtr:id><gtr:title>Estimation of relevant variables on high-dimensional biological patterns using iterated weighted kernel functions.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9de35975f0ad149e361f468ab626f6d"><gtr:id>d9de35975f0ad149e361f468ab626f6d</gtr:id><gtr:otherNames>Rojas-Galeano S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>F0FDABDF815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0ECA9064-2CB9-4F64-90D0-BBDB945DD1A6</gtr:id><gtr:title>The IL17F and IL17RA Genetic Variants Increase Risk of Cerebral Malaria in Two African Populations.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c10e5d15ee85e499880fac3e6d196d59"><gtr:id>c10e5d15ee85e499880fac3e6d196d59</gtr:id><gtr:otherNames>Marquet S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>58c19429d5f217.85113219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DD89F69-7C77-4857-AC0F-2D602E6FE375</gtr:id><gtr:title>Biomarker discovery by sparse canonical correlation analysis of complex clinical phenotypes of tuberculosis and malaria.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef197ae28105d280bc918435aa0a0b17"><gtr:id>ef197ae28105d280bc918435aa0a0b17</gtr:id><gtr:otherNames>Rousu J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>pm_16449_29_23637585</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E20A01BB-C850-4D60-922A-18E619EF692D</gtr:id><gtr:title>Affinity proteomics reveals elevated muscle proteins in plasma of children with cerebral malaria.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a786605d2bbd4a0c27d119700c76f5c"><gtr:id>8a786605d2bbd4a0c27d119700c76f5c</gtr:id><gtr:otherNames>Bachmann J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>54664116d10bc5.69153425</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2D90EBA-041E-4D5D-A020-0DD9F6AF8001</gtr:id><gtr:title>Rapid diagnostic algorithms as a screening tool for tuberculosis: an assessor blinded cross-sectional study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2323240ffc9e013ddf77c8524cac9048"><gtr:id>2323240ffc9e013ddf77c8524cac9048</gtr:id><gtr:otherNames>Ratzinger F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16449_29_23185397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A199FB6D-A174-484B-96B2-F9AA0A7B8996</gtr:id><gtr:title>A Functional IL22 Polymorphism (rs2227473) Is Associated with Predisposition to Childhood Cerebral Malaria.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c10e5d15ee85e499880fac3e6d196d59"><gtr:id>c10e5d15ee85e499880fac3e6d196d59</gtr:id><gtr:otherNames>Marquet S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c1929ddb6009.23277079</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34BC1EAD-6E77-422B-BFF9-FBD2D8A421D2</gtr:id><gtr:title>Haemoglobinuria among children with severe malaria attending tertiary care in Ibadan, Nigeria.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6b6dea061e95dbdd5adbe6d55c7d3f1"><gtr:id>a6b6dea061e95dbdd5adbe6d55c7d3f1</gtr:id><gtr:otherNames>Ajetunmobi WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>pm_16449_29_23039275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>432B7803-E6D9-49A7-938D-045DF8478100</gtr:id><gtr:title>Discriminating active from latent tuberculosis in patients presenting to community clinics.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/163c414a6665f2268f516fbd69f1ce2b"><gtr:id>163c414a6665f2268f516fbd69f1ce2b</gtr:id><gtr:otherNames>Sandhu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16449_29_22666453</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3CFB159-B1CB-4206-BF11-034682D0992A</gtr:id><gtr:title>Malaria induces anemia through CD8+ T cell-dependent parasite clearance and erythrocyte removal in the spleen.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/855d48f26940aba737985b34f4df0f18"><gtr:id>855d48f26940aba737985b34f4df0f18</gtr:id><gtr:otherNames>Safeukui I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>57a369d1426d87.21988120</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38F795F1-312F-45C5-A147-39DFEAEFA067</gtr:id><gtr:title>Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5d3fc8c769902839ff367508151414d"><gtr:id>d5d3fc8c769902839ff367508151414d</gtr:id><gtr:otherNames>Agranoff D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>2FD67BD912B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DF4628E-FC30-45DC-91C6-0C8E80F33A42</gtr:id><gtr:title>Severe childhood malaria syndromes defined by plasma proteome profiles.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f2bc8ccf2f361fa8c5a2eebff8fa9de"><gtr:id>1f2bc8ccf2f361fa8c5a2eebff8fa9de</gtr:id><gtr:otherNames>Burt? F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16449_29_23226502</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U117585869</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>